Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03012100
Title Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Indications

triple-receptor negative breast cancer

Therapies

Cyclophosphamide + Sargramostim

Cyclophosphamide + FR alpha peptide vaccine + Sargramostim

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.